Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II

Autor: Dietz, A. *, Wichmann, G., Kuhnt, T., Pfreundner, L., Hagen, R., Scheich, M., Kölbl, O., Hautmann, M.G., Strutz, J., Schreiber, F., Bockmühl, U., Schilling, V., Feyer, P., de Wit, M., Maschmeyer, G., Jungehülsing, M., Schroeder, U., Wollenberg, B., Sittel, C., Münter, M., Lenarz, T., Klussmann, J.P., Guntinas-Lichius, O., Rudack, C., Eich, H.T., Foerg, T., Preyer, S., Westhofen, M., Welkoborsky, H.J., Esser, D., Thurnher, D., Remmert, S., Sudhoff, H., Görner, M., Bünzel, J., Budach, V., Held, S., Knödler, M., Lordick, F., Wiegand, S., Vogel, K., Boehm, A., Flentje, M., Keilholz, U.
Zdroj: In Annals of Oncology October 2018 29(10):2105-2114
Databáze: ScienceDirect